N. Chaudhuri (Manchester (Greater Manchester), United Kingdom), S. Wort (Hampton (Middlesex), United Kingdom), J. Barberà (Barcelona, Spain), S. Günther (Le Kremlin-Bicêtre, France)
Screening for pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia in the French national reference centre V. Margelidon-Cozzolino (Lyon, France), C. Khouatra (Lyon, France), K. Ahmad (Lyon, France), J. Traclet (Lyon, France), N. Chebib (Lyon, France), S. Dupuis-Girod (Lyon, France), V. Cottin (Lyon, France)
| |
10 years’ experience of referral of ILD patients with Suspected PH to a National PH Service: Demographics and Outcomes S. Bax (London, United Kingdom), J. Jacobs (London, United Kingdom), V. Kouranos (London, United Kingdom), C. Bredy (London, United Kingdom), K. Dimopoulos (London, United Kingdom), A. Kempny (London, United Kingdom), S. Walsh (London, United Kingdom), A. Nair (London, United Kingdom), M. Kokosi (London, United Kingdom), G. Kier (Woolloongabba, Australia), E. Renzoni (London, United Kingdom), F. Chua (London, United Kingdom), P. George (London, United Kingdom), C. Mccabe (London, United Kingdom), M. Wilde (London, United Kingdom), A. Devaraj (London, United Kingdom), A. Wells (London, United Kingdom), L. Price* (London, United Kingdom), S. Wort* * Joint Final Author (London, United Kingdom)
| |
Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan. N. Tanabe (Chiba, Japan), H. Kumamaru (Tokyo, Japan), Y. Tamura (Tokyo, Japan), H. Taniguchi (Seto, Japan), N. Emoto (Kobe, Japan), Y. Yamada (Tokyo, Japan), O. Nishiyama (Osaka, Japan), I. Tsujino (Sapporo, Japan), H. Kuraishi (Nagano, Japan), H. Kimura (Kashihara, Japan), Y. Inoue (Osaka, Japan), Y. Morio (Tokyo, Japan), Y. Nakatsumi (Kanazawa, Japan), T. Satoh (Mitaka, Japan), M. Hanaoka (Matsumoto, Japan), T. Handa (Kyoto, Japan), M. Sumitani (Osaka, Japan), K. Kusaka (Kiyose, Japan), Y. Nishimura (Kobe, Japan), F. Sakamaki (Hachioji, Japan), M. Hatano (Tokyo, Japan), H. Matsubara (Okayama, Japan), K. Nakayama (Kobe, Japan), T. Kimura (Seto, Japan), S. Sakao (Chiba, Japan), M. Nishimura (Sapporo, Japan), H. Miyata (Tokyo, Japan), K. Tatsumi (Chiba, Japan)
| |
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity M. Graziani (Lyon, France), M. Reynaud-Gaubert (Marseille, France), E. Gomez (Nancy, France), J. Traclet (Lyon, France), K. Ahmad (Lyon, France), E. Bergot (Caen, France), L. Bertoletti (St Etienne, France), B. Camara (Grenoble, France), D. Israël-Biet (Paris, France), X. Jaïs (Le Kremlin-Bicêtre, France), L. Kiakouama-Maleka (Lyon, France), S. Marchand-Adam (Tours, France), D. Montani (Le Kremlin-Bicêtre, France), A. Nieves (Marseille, France), H. Nunes (Bobigny, France), F. Piegay (Lyon, France), L. Wemeau-Stervinou (Lille, France), V. Zarza (Valence, France), S. Polazzi (Lyon, France), A. Schott-Pethelaz (Lyon, France), S. Zeghmar (Lyon, France), M. Nasser (Lyon, France), V. Cottin (Lyon, France)
| |
Pulmonary hypertension in hypersensitivity pneumonitis. A. Tornyos (Graz, Austria), M. Trinker (Graz, Austria), V. Foris (Graz, Austria), S. Pfeiffer (Graz, Austria), B. Odler (Graz, Austria), P. Douschan (Graz, Austria), A. Avian (Graz, Austria), A. Leitner (Graz, Austria), A. Olschewski (Linz, Austria), G. Kovacs (Graz, Austria), H. Olschewski (Graz, Austria)
| |
Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension L. Price (Lon, United Kingdom), A. Kempny (Lon, United Kingdom), C. Mccabe (Lon, United Kingdom), K. Dimopoulos (Lon, United Kingdom), J. Kotecha (Lon, United Kingdom), C. Harries (Lon, United Kingdom), J. Barbosa (Lon, United Kingdom), N. Hopkinson (Lon, United Kingdom), A. Simonds (Lon, United Kingdom), A. Wells (Lon, United Kingdom), J. Wort (Lon, United Kingdom)
| |
Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease M. Ito (Ibaraki, Japan), K. Nemoto (Ibaraki, Japan), S. Oh-Ishi (Ibaraki, Japan), T. Yamamoto (Ibaraki, Japan), Y. Koshiishi (Ibaraki, Japan), A. Ito (Ibaraki, Japan), T. Shiraishi (Ibaraki, Japan), J. Yamazaki (Ibaraki, Japan), S. Inamura (Ibaraki, Japan), T. Akiyama (Ibaraki, Japan), T. Saito (Ibaraki, Japan), S. Fukai (Ibaraki, Japan)
| |
Diagnostic accuracy of echocardiography in pulmonary hypertension due to interstitial lung disease C. Heinze (Giessen, Germany), M. Richter (Giessen, Germany), N. Sommer (Giessen, Germany), K. Tello (Giessen, Germany), H. Ghofrani (Giessen, Germany), W. Seeger (Giessen, Germany), H. Gall (Giessen, Germany)
| |
Role of quantitative computed tomography in patients with severe precapillary pulmonary hypertension F. Coste (BORDEAUX, France), I. Benlala (BORDEAUX, France), G. Dournes (BORDEAUX, France), C. Dromer (PESSAC, France), E. Blanchard (PESSAC, France), F. Laurent (PESSAC, France), P. Berger (BORDEAUX, France)
| |
CT Based Arterial and Venous Morphologic Changes In Pulmonary Hypertension Associated with COPD F. Rahaghi (Boston, United States of America), V. Paz (Weston, United States of America), P. Nardelli (Boston, United States of America), J. Ross (Boston, United States of America), R. San José Estépar (Boston, United States of America), G. Washko (Boston, United States of America), F. Rahaghi (Boston, United States of America)
| |
Potential role of inflammatroy factors in Sleep Apnea Hypopnea Syndrome associated pulmonary hypertension J. Zhang (Yinchuan, China), S. Wang (Yinchuan, China), P. Zhang (Yinchuan, China)
| |
Association of pulmonary hypertension with sleep apnea in highlanders T. Sooronbaev (Bishkek, Kyrgyzstan), M. Furian (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), B. Estebesova (Bishkek, Kyrgyzstan), B. Osmonov (Bishkek, Kyrgyzstan), N. Marajapov (Bishkek, Kyrgyzstan), U. Sheraliev (Bishkek, Kyrgyzstan), P. Scheiwiller (Zurich, Switzerland), M. Lichtblau (Zurich, Switzerland), S. Saxer (Zurich, Switzerland), P. Bader (Zurich, Switzerland), T. Rochat (Geneva, Switzerland), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland)
| |
Pulmonary arterial pressure predicts nocturnal hypoxemia in CTEPH patients. C. Belge (Leuven, Belgium), D. Testelmans (Leuven, Belgium), B. Buyse (Leuven, Belgium), M. Delcroix (Leuven, Belgium)
| |
HIGH RATE OF SLEEP DISTURBANCE ABNORMALITIES IN A STABLE PULMONARY HYPERTENSION COHORT V. GIOVINI (buenos aires, Argentina), M. Mazzei (buenos aires, Argentina), N. Atamañuk (buenos aires, Argentina), D. Liteuka (buenos aires, Argentina), N. Facundo (buenos aires, Argentina)
| |
Effect of e-cigarette vapour extraction on vasoactive gene expression in human pulmonary artery smooth muscle and endothelial cells. A. Alqarni (Nottingham, United Kingdom), O. Brand (Nottingham, United Kingdom), A. Pasini (Nottingham, United Kingdom), M. Alshehri (Riyadh, Saudi Arabia), L. Pang (Nottingham, United Kingdom)
| |
Right ventricular tissue doppler echocardiography in pulmonary hypertension S. Pfeiffer (Graz, Austria), A. Avian (Graz, Austria), P. Douschan (Graz, Austria), V. Foris (Graz, Austria), A. Olschewski (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria)
| |
NT-proBNP variation in stable pulmonary arterial hypertension patients. I. Furtado (Porto, Portugal), C. Cruz (Porto, Portugal), A. Vigário (Porto, Portugal), S. Correia (Braga, Portugal), L. Carvalho (Porto, Portugal), F. Gonçalves (Porto, Portugal), M. Santos (Porto, Portugal), A. Reis (Porto, Portugal)
| |
Evaluation of the Validity and Reliability of the Turkish Translation of the Emphasis-10 Questionnaire In Patients with Pulmonary Hypertension P. Odevoglu (Istanbul, Turkey), R. Demir (Istanbul, Turkey), G. Okumus (Istanbul, Turkey), S. Küçükoglu (Istanbul, Turkey), G. Kuran Aslan (Istanbul, Turkey)
| |
The Post-Embolic Syndrome: Right Ventricular Post-injury Dysfunction? J. Lobo-Beristain (Vitoria-Gasteiz, Spain), Á. Alonso-Gómez (Vitoria-Gasteiz, Spain), A. Rivas-Guerrero (Vitoria-Gasteiz, Spain), C. Sanchez Vieco (Vitoria-Gasteiz, Spain), J. García-Fuertes (Vitoria-Gasteiz, Spain), R. Cobos-Campos (Vitoria-Gasteiz, Spain), R. Otero-Candelera (Sevilla, Spain), G. Osiris (Vitoria-Gasteiz, Spain)
| |
Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension M. Barros (Santiago, Chile), M. Fonseca (Santiago, Chile), M. Henriquez (Santiago, Chile)
| |